EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Programmatic implications of a sub-national TB prevalence survey in India

G. Prathiksha, S. Selvaraju, K. Thiruvengadam, A. Frederick, H. Murugesan, P. Rajendran, K. Nagarajan, M. Kumar, R. Krishnan, P. Kumaran, T.S. Selvavinayagam, C. Padmapriyadarsini

The International Journal of Tuberculosis and Lung Disease · 2024-07-01 · 28 (7) · 348-353

DOI: 10.5588/ijtld.23.0456 ↗
AbstractBibliografische Angaben

Abstract

BACKGROUND

Subnational TB estimates are crucial for making informed decisions to tailor TB control activities to local TB epidemiology.

METHODS

A cross-sectional survey was conducted among 143,005 individuals in Tamil Nadu, India. Participants were screened for symptoms and underwent chest X-ray (CXR). Participants with symptoms of TB and/or abnormal CXR were tested for TB using Xpert, smear, and liquid culture.

RESULTS

The prevalence of microbiologically confirmed pulmonary TB (MCPTB) was 212 (95% CI 184–239) per 100,000 population. The prevalence-to-notification ratio (P:N) in the state was 2.05 (95% CI 1.8–2.29). Low body mass index and diabetes together had a population attributable fraction of 54.15 (95% CI 45.68–61.97). Approximately 39% of the TB cases were asymptomatic and were identified only by CXR screening. In the general population, only 26.9% sought care at a health facility among those with symptoms suggestive of TB.

CONCLUSION

The programme needs to prioritise screening with CXR to potentially detect cases earlier and curtail the transmission and upscale molecular tests in the selected population to increase the yield of case finding. Innovative health education strategies must be devised to address health-seeking behaviour.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →